Sotos syndrome
Updates to Article Attributes
Sotos syndrome it is an autosomal dominant syndrome considered as a form of cerebral gigantism, mainly characterised by prenatal and postnatal overgrowth.
Epidemiology
There is no ethnic group predominance and has been detected throughout the world. The prevalence is not known but is estimated to be between 1:10,000 and 1:50,000 5.
Clinical presentation
- increased birth weight (between the 75th and 97th percentile) and length (above the 97th percentile) 5
- large head circumference at birth (usually above the 97th percentile) 5
- macrocephaly
- excessive growth in the first years of life
- craniofacial dysmorphisms such as dolichocephaly, prominent forehead, hypertelorism, epicanthic folds, flat nasal bridge, down-slanting palpebral fissures, high arched palate, premature eruption of teeth and pointed chin 6
- intellectual disability and developmental delay
Pathology
It is an autosomal dominant syndrome with the majority of cases being described as sporadic 5.
Radiographic features
Increased bone age documentation is a pre-requisite to diagnosis as it is thought that all cases have an advanced bone age at some time 5.
MRI/CT
Identifiable features include:
- cerebral ventricular abnormalities
- prominent trigone
- colpocephaly
- ventriculomegaly
- anomalies of midline structures
History and etymology
It was first described by Juan F. Sotos et al. in 1964 4.
Differential diagnosis
For a large head: see causes of macrocephaly.
-<p><strong>Sotos syndrome</strong> it is an autosomal dominant syndrome considered as a form of cerebral gigantism, mainly characterised by prenatal and postnatal overgrowth.</p><h4>Epidemiology</h4><p>There is no ethnic group predominance and has been detected throughout the world. The prevalence is not known but is estimated to be between 1:10,000 and 1:50,000 <sup>5</sup>.</p><h4>Clinical presentation</h4><ul>- +<p><strong>Sotos syndrome</strong> is an autosomal dominant syndrome considered as a form of cerebral gigantism, mainly characterised by prenatal and postnatal overgrowth.</p><h4>Epidemiology</h4><p>There is no ethnic group predominance and has been detected throughout the world. The prevalence is not known but is estimated to be between 1:10,000 and 1:50,000 <sup>5</sup>.</p><h4>Clinical presentation</h4><ul>